相关费用：选择性费用 ︾Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Commentaries、Article Commentary、Patient Perspectives：USD 2000/ EUR 1920/ GBP 1600
Brief Report：USD 2600/EUR 2500/ GBP 2080
Original Article、 Reviews、Review Article、Research Article、Fast Track：USD 4000/EUR 3840/GBP 3200
Letters to the editor、Letter to the Editor：0
If you choose not to publish Open Access in this journal, there is no Article Publishing Charge (APC).
Publication Charges
There are no submission fees, publication fees or page charges for this journal.
Color figures will be reproduced in color in your online article free of charge. If it is necessary for the figures to be reproduced in color in the print version, a charge will apply.
Charges for color figures in print are £300 per figure ($400 US Dollars; $500 Australian Dollars; €350). For more than 4 color figures, figures 5 and above will be charged at £50 per figure ($75 US Dollars; $100 Australian Dollars; €65). Depending on your location, these charges may be subject to local taxes.
出版地址：530 WALNUT STREET, STE 850, PHILADELPHIA, USA, PA, 19106
期刊简介：Cancer Investigation《癌症研究》（一年10期）. Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section.
